GENIL.E — Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Market Cap
TRY17.33bn
Enterprise Value
TRY17.92bn
Revenue
TRY8.15bn

Annual income statement for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.

	2019 December 31st	C2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,795	2,150	2,501	10,639	8,152
Cost of Revenue
Gross Profit	309	333	456	1,911	1,799
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,623	1,934	2,299	9,585	7,702
Operating Profit	172	216	203	1,055	450
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	159	217	301	501	262
Provision for Income Taxes
Net Income After Taxes	142	207	310	641	452
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	142	208	311	640	455
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	142	208	311	640	455
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.565	0.841	1.04	2.13	1.45
Dividends per Share